Literature DB >> 21466796

Gamma-glutamyl transferase level predicts the development of hypertension in Hong Kong Chinese.

Bernard M Y Cheung1, Kwok-Leung Ong, Annette W K Tso, Stacey S Cherny, Pak-Chung Sham, Tai-Hing Lam, Karen S L Lam.   

Abstract

BACKGROUND: Plasma activities of alkaline phosphatase, alanine aminotransferase (ALT), aspartate aminotransferase, and γ-glutamyl transferase (GGT) are often increased in cardiometabolic diseases. We investigated if hypertension is associated with increased activities of these plasma markers.
METHODS: We included 235 hypertensive and 708 normotensive subjects (mean age 47.3±9.6 and 58.0±10.2 years respectively) from the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS-2) in 2000-2004 who had drank <1/week. In the follow-up study in 2005-2008 (CRISPS-3), 126 out of the 708 subjects had developed hypertension.
RESULTS: Raised plasma ALT (OR=1.22 per SD of log-transformed level, P=0.045) and GGT (OR=1.38 per SD of log-transformed level, P=0.001) levels were associated with hypertension at baseline in CRISPS-2 after adjusting for covariates. Among subjects not on anti-hypertensive medications, plasma ALP, ALT and GGT were related to blood pressure (P<0.01). In subjects normotensive at CRISPS-2, plasma GGT, but not ALP, ALT and AST, was an independent predictor of new-onset hypertension at CRISPS-3 (OR=1.38 per SD of log-transformed level, P=0.020 and OR=2.68 for 3rd tertile vs. 1st tertile, P=0.004) after adjusting for covariates.
CONCLUSIONS: Among the 4 plasma markers, increased GGT activity is the strongest predictor for existing and new-onset hypertension in Hong Kong Chinese.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21466796     DOI: 10.1016/j.cca.2011.03.030

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  19 in total

Review 1.  Gamma-glutamyl transferase and cardiovascular disease.

Authors:  Gjin Ndrepepa; Adnan Kastrati
Journal:  Ann Transl Med       Date:  2016-12

2.  Gamma Glutamyl Transferase Activity is Associated With Both Paraoxonase Activity and Aortic Stiffness in Hypertensive Patients.

Authors:  Mehmet Yavuz Gözükara; Abdurrezzak Börekçi; Mustafa Gür; Nurten Aksoy; Taner Şeker; Onur Kaypaklı; Hakan Uçar; Caner Türkoğlu; Mevlüt Koç; İlyas Makca; Selahattin Akyol; Şahbettin Selek; Murat Çaylı
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

3.  Morning blood pressure surge is associated with serum gamma-glutamyltransferase activity in essential hypertensive patients.

Authors:  R Elsurer; B Afsar
Journal:  J Hum Hypertens       Date:  2014-08-28       Impact factor: 3.012

Review 4.  Role of gamma-glutamyltransferase in cardiovascular diseases.

Authors:  Shengyang Jiang; Donglin Jiang; Yijia Tao
Journal:  Exp Clin Cardiol       Date:  2013

5.  Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.

Authors:  Jennifer C Melvin; Crystal Rodrigues; Lars Holmberg; Hans Garmo; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mats Lambe; Wayel Jassem; Mieke Van Hemelrijck
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

6.  Contribution of Inflammation, Oxidative Stress, and Antioxidants to the Relationship between Sleep Duration and Cardiometabolic Health.

Authors:  Thirumagal Kanagasabai; Chris I Ardern
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

7.  Association of serum 25-hydroxyvitamin D levels with primary hypertension: a study from south India.

Authors:  Pramod Kumar Kuchulakanti; Jaydip Ray Chaudhuri; Urmila Annad; Naveen Reddy Samala; Lakshumaiah Tallapaneni; Banda Balaraju; Vcs Srinivasarao Bandaru
Journal:  Hypertens Res       Date:  2020-01-21       Impact factor: 3.872

Review 8.  Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis.

Authors:  Cun-Fei Liu; Yu-Ting Gu; Hai-Ya Wang; Ning-Yuan Fang
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999-2016.

Authors:  Chun-On Lee; Hang-Long Li; Man-Fung Tsoi; Ching-Lung Cheung; Bernard Man Yung Cheung
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

10.  Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension.

Authors:  Li-Na Zhang; Pan-Pan Liu; Lingyan Wang; Fang Yuan; Leiting Xu; Yanfei Xin; Li-Juan Fei; Qi-Long Zhong; Yi Huang; Limin Xu; Ling-Mei Hao; Xu-Jun Qiu; Yanping Le; Meng Ye; Shiwei Duan
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.